OrbiMed

SystImmune Inc. was founded in 2014 and is located in Redmond, Washington. It is a biopharmaceutical company focused on treating cancer by developing novel therapeutic bispecific and multispecific antibodies as well as antibody-drug conjugates (ADCs). Our goal is to create biologics through systemic intervention in the solid tumor microenvironment, directly attacking tumors or activating the immune system to attack tumors. We are a team of experienced immuno-oncology scientists leveraging multiple technology platforms to develop world-class antibody-based drug therapies.